THE MCMANUS GROUP for GENENTECH
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Follow-on biologics provisions in P.L. 111-148, "Patient Protection and Affordable Care Act."
Foreign entity interest: 100% ownership by Roche Holding, Ltd., 4070 Basel, Switzerland
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| NICK SHIPLEY | Legislative Director, Rep. Jay Inslee |
Medicare/Medicaid MMM
Opposition to Medicare rebates in P.L. 111-148, "Patient Protection and Affordable Care Act." Independent Payment Advisory Board provisions in P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010."
Foreign entity interest: 100% ownership by Roche Holding, Ltd., 4070 Basel, Switzerland
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| NICK SHIPLEY | Legislative Director, Rep. Jay Inslee |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.